Robert Phelan Sells 2,186 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CFO Robert Phelan sold 2,186 shares of Adtalem Global Education stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $135.15, for a total transaction of $295,437.90. Following the sale, the chief financial officer directly owned 48,306 shares in the company, valued at $6,528,555.90. The trade was a 4.33% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

Shares of CVSA opened at $127.85 on Thursday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. Adtalem Global Education Inc. has a one year low of $86.97 and a one year high of $156.26. The business has a 50-day moving average of $125.00. The stock has a market capitalization of $4.35 billion, a price-to-earnings ratio of 18.16, a PEG ratio of 0.94 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The firm had revenue of $501.38 million for the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Analysts expect that Adtalem Global Education Inc. will post 8.99 EPS for the current fiscal year.

Hedge Funds Weigh In On Adtalem Global Education

An institutional investor recently bought a new position in Adtalem Global Education stock. Kendall Capital Management purchased a new stake in shares of Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CVSA. Weiss Ratings reissued a “hold (c+)” rating on shares of Adtalem Global Education in a research report on Friday, May 22nd. Truist Financial lifted their price target on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Finally, Barrington Research reiterated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.